文献速递淋巴瘤白血病

克隆扩增的CD8+ T细胞在次级淋巴组织中发生功能性耗竭并控制慢性淋巴细胞白血病发展

Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.
PubMed 文献 · Leukemia · 2018-09-28

该研究利用Eµ-TCL1小鼠模型及CLL患者血液和淋巴结样本,发现一群随CLL进展而扩增并控制疾病发展的寡克隆CD8+效应T细胞;较高比例CD8+效应T细胞产生IFNγ,中和IFNγ可加速小鼠CLL进展;小鼠次级淋巴器官中扩增的CD8+效应T细胞呈现活化诱导耗竭特征;CLL患者淋巴结中特异性积聚一群耗竭CD8+ T细胞。

要点

  • 寡克隆CD8+效应T细胞随CLL进展扩增并控制疾病发展。
  • 较高比例CD8+效应T细胞产生IFNγ,中和IFNγ加速小鼠CLL进展。
  • CLL患者淋巴结特异性积聚耗竭CD8+ T细胞,外周血中不积聚。

核心结论

  • CD8+ T细胞在抑制CLL进展中发挥非冗余作用,其功能障碍可作为该恶性肿瘤的免疫治疗靶点。

研究设计与样本

  • 研究利用Eµ-TCL1小鼠CLL模型以及CLL患者的血液和淋巴结样本,探究CLL中抗肿瘤免疫反应的存在并表征相关免疫细胞群体。

主要发现

  • 鉴定出一群随CLL进展而扩增并控制疾病发展的寡克隆CD8+效应T细胞。
  • 较高比例的CD8+效应T细胞产生IFNγ,中和IFNγ导致小鼠CLL进展更快。
  • 小鼠疾病受累组织中扩增的CD8+效应T细胞表型和功能分析显示显著差异,次级淋巴器官中的细胞具有活化诱导T细胞耗竭的标志。
  • CLL患者淋巴结中特异性积聚一群耗竭CD8+ T细胞,而外周血中不积聚。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic lymphocytic leukemia (CLL) is associated with substantial alterations in T-cell composition and function. However, the role of T-cells in CLL remains largely controversial. Here, we utilized the Eµ-TCL1 mouse model of CLL as well as blood and lymph node samples of CLL patients to investigate the existence of anti-tumoral immune responses in CLL, and to characterize involved immune cell populations. Thereby, we identified an oligoclonal CD8+ effector T-cell population that expands along with CLL progression and controls disease development. We further show that a higher percentage of CD8+ effector T-cells produces IFNγ, and demonstrate that neutralization of IFNγ results in faster CLL progression in mice. Phenotypical and functional analyses of expanded CD8+ effector T-cells show significant differences in disease-affected tissues in mice, with cells in secondary lymphoid organs harboring hallmarks of activation-induced T-cell exhaustion. Notably, we further describe a respective population of exhausted CD8+ T-cells that specifically accumulate in lymph nodes, but not in peripheral blood of CLL patients. Collectively, these data emphasize the non-redundant role of CD8+ T-cells in suppressing CLL progression and highlight their dysfunction that can be exploited as target of immunotherapy in this malignancy.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hanna BS, Roessner PM, Yazdanparast H, et al. Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues. Leukemia. 2018. PMID: 30267008. doi:10.1038/s41375-018-0250-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。